E Fund Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

E Fund Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,338	Closed	-$740K	–	384
2023 Q4	$740K	Sell	2,338 -144	-6%	-$28K	0.05%	107
2023 Q3	$420K	Buy	2,482 +519	+26%	+$97.6K	0.03%	161
2023 Q2	$426K	Sell	1,963 -194	-9%	-$41.6K	0.03%	150
2023 Q1	$392K	Buy	2,157 +14	+0.7%	+$2.68K	0.03%	173
2022 Q4	$421K	Buy	2,143 +229	+12%	+$49.1K	0.04%	172
2022 Q3	$431K	Sell	1,914 -2,402	-56%	-$486K	0.04%	163
2022 Q2	$546K	Buy	4,316 +1,709	+66%	+$196K	0.05%	130
2022 Q1	$331K	Buy	+2,607	New	+$294K	0.01%	173

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

E Fund Management's KRTX Position: Q1 2024 in Review

E Fund Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,338 shares — an estimated $740K sold.

E Fund Management first reported a position in KRTX in Q1 2022 and held it in 8 quarters. The position peaked at $740K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

E Fund Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
E Fund Management sold 2,338 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $740K.
E Fund Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
E Fund Management's Karuna Therapeutics, Inc. Common Stock position peaked at $740K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.